I'm sorry, but you don't know what you are talking about!
A patient does not "take" CAR-T. CAR-T is a medical procedure that includes extracting T cells from the patient, genetically engineering those cells, and reinserting them back into the patient to fight the disease (cancer). The reinsertion takes place in a hospital setting over a short period of time (hours), and the modified T cells then seek out and destroy the cancer cells (usually a blood cancer) over a period of a few days. It is not a simple procedure and is about as modern as medicine can be. It also has possible AEs (adverse effects) that can potentially be lethal.
To equate CAR-T assessment to a blood test is ludicrous.
You should be careful about promoting such crazy notions.
You are having a severe comprehension problem.
This study is for those on, or soon to take, CAR-T therapy. They are already known to have an issue requiring that.
Their doctors did not know that the ALC test could determine efficacy at 15 days, until now.
Get your head out so you can say, “icclearly,” icclearly.